Company Filing History:
Years Active: 2011
Title: Innovations of Jung-Eun Kim in Endothelial Cell Research.
Introduction
Jung-Eun Kim is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of biomedical research, particularly in the area of endothelial cell interactions. His work focuses on the development of peptides that can influence cellular behaviors, which has implications for various medical conditions.
Latest Patents
Jung-Eun Kim holds a patent for the "Use of a peptide that interacts with αvβ3 integrin of endothelial cells." This invention relates to a method for inhibiting endothelial cell adhesion, migration, and angiogenesis. The peptide consists of at least 18 amino acids, including tyrosine-histidine (TY) or asparagines-histidine (NH), along with at least three hydrophobic amino acids with bulky side chains. This innovation provides a method for treating or preventing diseases related to angiogenesis.
Career Highlights
Jung-Eun Kim is affiliated with the Kyungpook National University Industry-Academic Cooperation Foundation. His role at this institution allows him to engage in cutting-edge research and collaborate with other experts in the field. His contributions have been recognized within the academic community, and he continues to advance knowledge in his area of expertise.
Collaborations
Jung-Eun Kim has worked alongside notable colleagues, including Ju-Ock Nam and Ha-Won Jeong. These collaborations have fostered a productive research environment, leading to innovative solutions in endothelial cell research.
Conclusion
Jung-Eun Kim's work exemplifies the intersection of innovation and medical research. His patented peptide technology holds promise for future treatments of angiogenesis-related diseases. His contributions continue to impact the scientific community positively.